Similar articles

• Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.

  Mottaghy K, Oedekoven B, Bey R, Schmid-Schönbein H. Mottaghy K, et al. Trans Am Soc Artif Intern Organs. 1985;31:534-6. Trans Am Soc Artif Intern Organs. 1985. PMID: 3939276 No abstract available.
• [Anticoagulation for plasmapheresis].

  Amemiya H, Sekihara H, Kobayashi T, Koiwa F, Niikura K. Amemiya H, et al. Nihon Rinsho. 2004 May;62 Suppl 5:323-7. Nihon Rinsho. 2004. PMID: 15197938 Review. Japanese. No abstract available.
• [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].

  Vukusich A, Avalos C, Orellana G, Cifuentes C, Rivas J, Calderón F. Vukusich A, et al. Rev Med Chil. 1995 Jun;123(6):735-41. Rev Med Chil. 1995. PMID: 8525227 Clinical Trial. Spanish.
• The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).

  Mellgren K, Skogby M, Friberg LG, Tengborn L, Wadenvik H. Mellgren K, et al. Thromb Haemost. 1998 Feb;79(2):342-7. Thromb Haemost. 1998. PMID: 9493588
• [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].

  Delsart D, Chambefort V, Decousus H. Delsart D, et al. Rev Prat. 2001 Sep 1;51(13):1489-97. Rev Prat. 2001. PMID: 11601082 Review. French. No abstract available.